51
In band
Moving averages
SMA 200$2.65+0.75%
Company profile
Editas Medicine, Inc., a clinical-stage genome editing company, is focused on developing transformative genomic drugs to treat a variety of serious diseases. The company is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$422.35M
P/E ratioNone
EPS$-0.68
Beta2
Dividend yield0.00%
52-week high$4.33
52-week low$1.66
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
CAPR
Capricor Therapeutics Inc
RSI 42
ALLO
Allogene Therapeutics Inc
RSI 29
ALT
Altimmune Inc
RSI 27
ARCT
Arcturus Therapeutics Holdings Inc
RSI 45
AGEN
Agenus Inc
RSI 47
ARTV
Artiva Biotherapeutics Inc
RSI 21
RSI alerts for EDIT
An email when EDIT closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:09 PM EDT